Isis Pharmaceuticals, Inc. (ISIS) Posts Mixed Q4 Results

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.20), $0.02 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $32.4 million versus the consensus estimate of $30.3 million.

For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• KB Home (KBH) PT Raised to $56 at Truist Securities
• TD Cowen cuts Flowserve to Hold, flags guidance reset risk amid Mideast woes